admissions@cyberlawacademy.com | +91-XXXXXXXXXX
🔍 Module 2 - Part 4 of 8

Patent Examination Process

Navigate the examination process from the First Examination Report (FER) to grant. Master the art of responding to Controller objections, claim amendments, hearing procedures, and effective timeline management for successful patent prosecution.

First Examination Report (FER)

After filing Form 18 (Request for Examination), the application is assigned to a patent examiner who conducts a thorough examination and issues the First Examination Report (FER). The FER is the first official communication from the Patent Office detailing objections to the application.

Rule 24B - First Examination Report
Where the examiner finds that the application or specification or any document submitted does not comply with the requirements of the Act or Rules, the Controller shall communicate the report of the examiner to the applicant and require correction of deficiencies.

Contents of FER

A typical FER contains:

  • Prior Art Citations: Patents and publications cited against novelty and inventive step
  • Section 3 Objections: If any claim falls under excluded subject matter
  • Claim Objections: Clarity, support, scope issues
  • Specification Deficiencies: Insufficient description, enablement issues
  • Formal Objections: Form/fee deficiencies, document issues
  • Unity of Invention: If claims cover multiple inventions
💡 Time Limit for Response

The applicant must respond to the FER within 6 months from the date of issuance. This period can be extended by a maximum of 3 months by filing Form 4 with the prescribed extension fee. No further extension is permitted.

Common Controller Objections and Responses

Objection 1: Lack of Novelty (Anticipation)

The examiner cites prior art documents (D1, D2, etc.) and alleges that the claimed invention is anticipated by one or more of these documents.

Response Strategy:
  • Analyze each cited document carefully - does it really disclose ALL claim elements?
  • Distinguish the claims by pointing out features absent in prior art
  • Amend claims to include distinguishing features
  • Argue that document does not provide "clear and unmistakable direction"
  • Challenge the relevance of the citation (different technical field)
Objection 2: Lack of Inventive Step (Obviousness)

The examiner combines multiple prior art documents to argue that the claimed invention would have been obvious to a person skilled in the art.

Response Strategy:
  • Challenge the combination - is there motivation to combine?
  • Argue unexpected technical effect or synergistic result
  • Present secondary evidence: commercial success, long-felt need, failure of others
  • Argue that prior art teaches away from the invention
  • Emphasize technical advance or economic significance
Objection 3: Section 3(d) - New Form of Known Substance

For pharmaceutical applications, the examiner alleges the claims are for a new form of a known substance without enhanced efficacy.

Response Strategy:
  • Provide comparative data showing enhanced therapeutic efficacy
  • Demonstrate improved bioavailability leading to better therapeutic outcome
  • Show reduced toxicity with maintained efficacy
  • Argue the compound is not a "known substance" under Section 3(d)
  • Submit clinical or pre-clinical data supporting enhanced efficacy
Objection 4: Section 3(k) - Computer Program Per Se

For software-related inventions, the examiner alleges claims are directed to computer programs per se.

Response Strategy:
  • Emphasize the technical problem solved and technical effect achieved
  • Draft claims as method/system, not pure software
  • Show hardware interaction and technical implementation
  • Highlight improvement in computer functioning or technology
  • Follow CRI (Computer Related Inventions) Guidelines
Objection 5: Insufficient Description (Non-Enablement)

The specification does not sufficiently describe the invention to enable a person skilled in the art to perform it.

Response Strategy:
  • Point out where enablement is provided in the specification
  • Argue that POSITA would understand with reasonable experimentation
  • Limit claims to enabled embodiments
  • Submit additional experimental data as supplementary information
Objection 6: Claims Not Supported by Description

The scope of claims exceeds what is disclosed and supported in the specification.

Response Strategy:
  • Identify support for each claim element in the specification
  • Amend claims to match the described embodiments
  • Add dependent claims for specific embodiments
  • Narrow broad claim language to supported scope

Claim Amendments

Claim amendments are a critical tool during prosecution to overcome objections and secure patent grant. However, amendments are subject to important restrictions.

Section 59 - Amendment of Application and Specification
No amendment shall be allowed to be made which would have the effect of making the application as amended relate to more than one invention, or which adds any subject matter not in substance disclosed in the specification as filed.

Principles Governing Amendments

  1. No New Matter: Cannot add subject matter not disclosed in original specification
  2. No Broadening: Cannot expand claim scope after grant (pre-grant broadening may be allowed)
  3. Unity: Amendments must not result in multiple inventions
  4. Fair Basis: Amended claims must be supported by the specification

Types of Permissible Amendments

  • Adding limitations from specification to narrow claims
  • Combining dependent claims into independent claims
  • Correcting clerical errors
  • Clarifying claim language without changing scope
  • Deleting claims or narrowing claim scope
💡 Documentation of Amendments

When filing amendments, provide: (1) Clean copy of amended specification/claims; (2) Marked-up copy showing all changes; (3) Explanation of amendments and their basis in the original specification; (4) Arguments addressing the Controller's objections.

Hearing Procedures

If objections cannot be resolved through written submissions, the applicant may request a hearing before the Controller. Hearings provide an opportunity for oral arguments and clarification.

When is a Hearing Required?

  • Complex technical or legal issues requiring explanation
  • Disagreement persists after written response to FER
  • Opposition proceedings (post-grant opposition has hearing as of right)
  • Applicant believes written response insufficient to convey position

Hearing Procedure

  1. Request: File request for hearing with Form 19
  2. Notice: Controller issues hearing notice with date, time, venue
  3. Preparation: Prepare detailed submissions, exhibits, arguments
  4. Representation: Applicant/agent/advocate can appear
  5. Presentation: Oral arguments presented to Controller
  6. Record: Written record of hearing maintained
  7. Decision: Controller issues written decision after hearing
💡 Hearing Tips

Prepare written synopsis of arguments; bring prior art documents and specification copies; be concise and focus on key issues; address each objection systematically; be prepared for Controller's questions; request adjournment if new issues arise.

Grant of Patent

Once all objections are overcome and opposition proceedings (if any) are decided favorably, the Controller proceeds to grant the patent.

Section 43 - Grant of Patents
Where an application for a patent has been found to be in order for grant, the patent shall be granted to the applicant with effect from the date of filing of the application.

Grant Process

  1. Controller satisfied all requirements met
  2. No pending opposition or opposition decided favorably
  3. Patent granted with effect from filing date
  4. Patent published in Official Gazette/Patent Journal
  5. Certificate of Patent issued to patentee
  6. Patent term: 20 years from filing date

Post-Grant Requirements

  • Renewal Fees: Annual fees payable from 3rd year onwards
  • Working Statement: Form 27 to be filed annually
  • Assignment Recording: Any transfer must be recorded
  • Marking: Products should bear patent number

Timeline Management

Key Deadlines in Patent Prosecution
Filing to Publication: 18 months
Application automatically published 18 months from priority date. Early publication possible on request (Form 9).
Request for Examination: 48 months
Form 18 must be filed within 48 months from priority date. Failure results in deemed withdrawal.
FER to Response: 6 months (+ 3 months extension)
All objections must be addressed within this time, else application deemed abandoned.
Post-Grant Opposition: 12 months from grant publication
Any person interested can file opposition within 1 year of grant publication.
Working Statement: Annually (March 31)
Form 27 must be filed every year with details of working of patent in India.
Renewal Fees: Annually from Year 3
Progressive fees starting from 3rd year. Late payment with surcharge possible within 6 months of due date.
💡 Best Practices for Timeline Management

1. Maintain docket/calendar with all deadlines
2. Set reminders well in advance of due dates
3. Track foreign counterparts for Form 3 updates
4. Plan examination request strategically (later gives more time)
5. Use early publication if quick grant needed

Part 4 Quiz: Patent Examination Process

Test your understanding of patent examination procedures.

Question 1 of 10
What is the standard time limit for responding to the First Examination Report (FER)?
  • A) 3 months
  • B) 6 months
  • C) 12 months
  • D) 18 months
Correct Answer: B
The standard time limit for responding to the FER is 6 months from the date of issuance. This can be extended by a maximum of 3 months (total 9 months) by filing Form 4 with the prescribed extension fee.
Question 2 of 10
Under Section 59, which type of amendment is NOT permitted?
  • A) Narrowing claim scope
  • B) Adding new matter not disclosed in original specification
  • C) Correcting clerical errors
  • D) Combining dependent claims
Correct Answer: B
Section 59 prohibits amendments that add "any subject matter not in substance disclosed in the specification as filed." This is the no-new-matter rule that prevents applicants from introducing concepts not originally disclosed.
Question 3 of 10
When does the patent term of 20 years begin?
  • A) From date of grant
  • B) From date of filing
  • C) From date of publication
  • D) From date of examination request
Correct Answer: B
Under Section 53, the patent term is 20 years from the date of filing of the patent application, not from the date of grant. This is consistent with TRIPS requirements.
Question 4 of 10
Form 27 relates to:
  • A) Request for examination
  • B) Opposition proceedings
  • C) Statement of working of patent
  • D) Assignment of patent
Correct Answer: C
Form 27 is the Statement of Working required under Section 146. Every patentee must annually file this form disclosing whether the patented invention is being worked in India, extent of working, and reasons if not worked.
Question 5 of 10
Renewal fees are payable from which year of the patent term?
  • A) 1st year
  • B) 2nd year
  • C) 3rd year
  • D) 4th year
Correct Answer: C
Renewal fees are payable starting from the 3rd year of the patent term. The fees increase progressively over the patent term. Late payment within 6 months of due date is allowed with a surcharge.
Question 6 of 10
What is the maximum extension available for responding to FER?
  • A) 3 months
  • B) 6 months
  • C) 9 months
  • D) 12 months
Correct Answer: A
The maximum extension beyond the standard 6-month period is 3 months, making the total maximum response time 9 months. This extension must be requested via Form 4 with payment of the prescribed extension fee.
Question 7 of 10
Which form is used to request a hearing before the Controller?
  • A) Form 9
  • B) Form 18
  • C) Form 19
  • D) Form 27
Correct Answer: C
Form 19 is used to request a hearing before the Controller of Patents. The Controller will then issue a hearing notice specifying the date, time, and venue for the hearing.
Question 8 of 10
To overcome a Section 3(d) objection for pharmaceuticals, what must the applicant demonstrate?
  • A) Improved manufacturing process
  • B) Enhanced therapeutic efficacy
  • C) Commercial success
  • D) Lower production cost
Correct Answer: B
As established in Novartis v. Union of India, to overcome a Section 3(d) objection for pharmaceutical substances, the applicant must demonstrate enhanced "therapeutic efficacy" - not merely improved physical or chemical properties.
Question 9 of 10
From when is the patent effective after grant under Section 43?
  • A) Date of grant
  • B) Date of filing of application
  • C) Date of publication
  • D) Date of request for examination
Correct Answer: B
Under Section 43, the patent shall be granted "with effect from the date of filing of the application." This means the patentee has rights from the filing date, and the 20-year term is calculated from this date.
Question 10 of 10
What happens if Form 18 (Request for Examination) is not filed within the prescribed period?
  • A) Application automatically proceeds to examination
  • B) Application is deemed withdrawn
  • C) Late fee is imposed
  • D) Application is put in abeyance
Correct Answer: B
If Form 18 (Request for Examination) is not filed within 48 months from the priority date or filing date, the application is deemed to have been withdrawn. There is no provision for late filing or restoration.